High-Value Federal Grants ($5M+) — July 01, 2026

HARRIS CORPORATION received a $1.24B defense-related contract from the Department of Transportation, the largest award in this period by a wide margin. The high materiality score (8/10) suggests significant revenue impact, though annual revenue estimates and pricing risk are unknown, limiting conviction.

Leidos won a $113.5M cost-plus-fixed-fee delivery order from NIH for agile software development supporting the eRA grants management system. This low-risk, stable-margin contract ties Leidos to growing federal health IT budgets, with potential option exercise doubling value to $247.1M.

Amentum Services won a $204M cost-plus-fixed-fee contract for NASA lab support at Kennedy Space Center. With $154M already outlayed and the contract expiring August 2023, this signal is neutral—stable past cash flows but no future upside without recompete.

Management & Training Corporation won a $115.5M firm-fixed-price contract to operate the Atterbury Job Corps Center, with $103.8M obligated. The medium-risk pricing structure and contract end in November 2024 create near-term revenue uncertainty without visible follow-on.

HARRIS CORPORATION's $1.24B award represents 74.6% of total aggregate obligation, creating extreme single-contract concentration risk. Any protest, performance issue, or budget rescission could materially impact the company's revenue stream.

Management & Training Corporation's $103.8M firm-fixed-price DOL contract carries medium pricing risk. Cost overruns on Job Corps operations could compress margins, while the contract expiration in November 2024 without extension options threatens revenue continuity.

Amentum Services' NASA contract expires August 2023 with no option beyond that date. NASA's testing lab budget is stable, but failure to win recompete could result in a $34M annual revenue loss for Jacobs Engineering.

HARRIS CORPORATION's $1.24B DOT award lacks disclosed competition signal, raising concerns about potential bid protests or congressional scrutiny. Undisclosed competitive dynamics could increase execution risk.

Leidos' $113.5M NIH contract for agile software development positions the company for follow-on work as NIH continues digital modernization of grants management. Options could expand total value to $247.1M, offering a 2.2x upside.

HARRIS CORPORATION's $1.24B DOT contract—labeled 'defense'—could indicate expansion into transportation security or infrastructure roles traditionally held by defense primes. This contract may serve as a gateway to broader DOD or DHS opportunities.

Management & Training Corporation's DOL Job Corps contract recompete before November 2024 presents a direct retention opportunity. Given the program's stable funding, successful re-award would extend a $19.2M annual revenue stream for 5+ years.

Leidos' $113.5M NIH award and Amentum's $204M NASA contract both support civilian agency technology modernization and lab operations, reflecting sustained non-defense IT and services spending. Unlike defense budgets, which face CR uncertainty, civilian grants management and testing support contracts have shown consistent funding.

HARRIS CORPORATION's $1.24B contract accounts for 74.6% of total obligation value, a stark single-award concentration. This pattern suggests high dependence on a one-time DOT program, which amplifies both upside and downside moves for HARRIS CORPORATION relative to peers with diversified portfolios.

Leidos' $113.5M NIH contract and Amentum's $204M NASA contract are both cost-plus-fixed-fee, reducing profit risk for contractors. This structure incentivizes stable margins and predictable cash flows in civilian R&D and IT services, contrasting with firm-fixed-price contracts like Management & Training Corporation's DOL award.

{"entity"=>"HARRIS CORPORATION", "reason"=>"Massive $1.24B DOT contract drives 74.6% of aggregate value—any protest, performance issue, or budget cut would be materially impactful.", "trigger"=>"GAO protest decision on DOT award or DOT budget rescission announcement"}

{"entity"=>"Leidos, Inc.", "reason"=>"$113.5M NIH contract with option upside to $247.1M; strong alignment with federal IT modernization.", "trigger"=>"NIH option exercise announcement or new eRA-related task orders"}

{"entity"=>"Jacobs Engineering Group (via Amentum Services)", "reason"=>"$204M NASA contract expires August 2023; recompete outcome is critical for $34M annual revenue stream.", "trigger"=>"NASA recompete solicitation release or award decision"}

{"entity"=>"Management & Training Corporation", "reason"=>"$103.8M DOL Job Corps contract expires November 2024; re-award is needed to sustain labor-intensive revenue base.", "trigger"=>"DOL recompete solicitation for Atterbury Job Corps Center"}

{"entity"=>"Civilian IT Services Sector (ETF: PPA, SHLD)", "reason"=>"Leidos and Amentum contracts highlight stable civilian IT and lab spending, with no defense budget uncertainty.", "trigger"=>"Federal budget appropriations for NIH and NASA in FY2024-2025"}